RecruitingNot ApplicableNCT05695430

Brief Cognitive Behavioral Therapy for People With Physical Disabilities

Telehealth-delivered Brief Cognitive Behavioral Therapy to Prevent Suicides in People With Physical Disabilities


Sponsor

Ohio State University

Enrollment

60 participants

Start Date

Mar 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to examine the effectiveness of a psychotherapy (non-medication) treatment, Brief Cognitive Behavioral Therapy for Suicide Prevention, in reducing suicide ideation and attempts for people with physical disabilities.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a brief, online cognitive behavioral therapy (CBT) program designed specifically for people with physical disabilities who are experiencing suicidal thoughts. The goal is to reduce suicide risk using a short, accessible therapy delivered via video. **You may be eligible if...** - You are 18 or older - You have a disability affecting your vision, hearing, or mobility - You have had suicidal thoughts in the past week, or attempted suicide in the past month **You may NOT be eligible if...** - You are unable to provide informed consent - You do not have internet access and a webcam Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALBrief Cognitive Behavioral Therapy for People with Physical Disabilities

12 sessions of of Brief Cognitive Behavioral Therapy that has been adapted for people with physical disabilities will be administered through telehelath.


Locations(1)

The Ohio State Universitty Wexner Medical Center

Columbus, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05695430


Related Trials